Form 4 for BSX Boston Scientific
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-03 · accession 0001225208-22-012296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-05 | 2022-05-16+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -256 | 110.6K | -0.2% | $0 |
| D | 2022-12-05 | 2022-12-03 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.60 | -296 | 111.0K | -0.3% | -$13.8K |
| D | 2022-12-05 | 2022-12-03 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +649 | 111.3K | +0.6% | $0 |
| D | 2022-12-05 | 2022-12-03 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | -649 | 649 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | G | D | 26 | $0.00 | 110,290 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-03 | F | D | 296 | $46.60 | 110,992 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-03 | M | A | 649 | $0.00 | 111,288 | D | — | — | (F2) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 4 | Common | Common Stock | 2022-11-01 | G | D | 230 | $0.00 | 110,639 | D | — | — | (F1) Includes shares acquired on June 30, 2022 under the Boston Scientific Employee Stock Purchase Plan (formerly Boston Scientific Global Employee Stock Purchase Plan) based upon the most current data available. |
| 5 | Derivative | Deferred Stock Units | 2022-12-03 | M | D | 649 | $0.00 | 649 | D | — · — to 2023-12-03 | 649 Common Stock | (F2) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F3) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 3, 2019, the first anniversary of the date of grant. |